Comparison of B lineage markers confirmed that CD79a provides far superior sensitivity for interstitial B cells compared to CD19, establishing it as the requisite anchor for B cell burden assessment in FFPE lupus nephritis tissue. The gene discussed is CD19; the disease is lupus nephritis.